Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 196–210 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3865 CD2AP Gene Sequencing (Focal Segmental Glomerulosclerosis Type 3) DNA Test This test evaluates the CD2AP gene for pathogenic variants associated with autosomal dominant Focal Segmental Glomerulosclerosis Type 3 (FSGS3).	Whole blood, extracted DNA, or FTA card dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CD2AP gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling session mandatory"] Indications ["Diagnosis of suspected FSGS Type 3", "Family screening for FSGS Type 3", "Personalized nephrology management"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: N04.1 Clinical summary This test evaluates the CD2AP gene for pathogenic variants associated with autosomal dominant Focal Segmental Glomerulosclerosis Type 3 (FSGS3).
TEST-3569 CD3G Gene Cone-Rod Dystrophy Type 17 DNA Test (NGS) This test detects pathogenic or likely pathogenic variants in the CD3G gene associated with cone-rod dystrophy type 17.	Peripheral Blood (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD3G gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected cone-rod dystrophy type 17", "Family history of inherited retinal dystrophy", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81290-1 ICD-10: H35.54 Clinical summary This test detects pathogenic or likely pathogenic variants in the CD3G gene associated with cone-rod dystrophy type 17.
TEST-3802 CD46 Gene (Atypical Hemolytic Uremic Syndrome Type 2) Susceptibility Genetic Test This genetic test identifies pathogenic variants in the CD46 gene associated with atypical hemolytic uremic syndrome type 2.	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD46 gene pathogenic variants", "Loss-of-function mutations"] Parameters [] Preparation [] Indications ["Personal or family history of atypical hemolytic uremic syndrome", "Early-onset renal failure", "Recurrent episodes", "Documented complement pathway abnormality", "Asymptomatic first-degree relatives of a proband with a confirmed CD46 pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 81269-9 ICD-10: D59.3 Clinical summary This genetic test identifies pathogenic variants in the CD46 gene associated with atypical hemolytic uremic syndrome type 2.
TEST-4299 CDKL5 Gene Analysis for Early Infantile Epileptic Encephalopathy Type 2 (NGS) Test This test detects pathogenic variants in the CDKL5 gene associated with Early Infantile Epileptic Encephalopathy Type 2 (EIEE2).	Peripheral whole blood (EDTA tube) or FTA card / DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKL5 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 2 (EIEE2)", "CDKL5 deficiency disorder"] Measurement technique Confirm with laboratory Codes LOINC: 97515-4 ICD-10: G40.4, G40.819, Z13.71 Clinical summary This test detects pathogenic variants in the CDKL5 gene associated with Early Infantile Epileptic Encephalopathy Type 2 (EIEE2).
TEST-2139 CDKN1C Gene Beckwith-Wiedemann Syndrome Genetic Test This test sequences the CDKN1C gene to detect mutations associated with Beckwith-Wiedemann syndrome.	Peripheral Whole Blood (EDTA) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKN1C gene mutations", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any ongoing medications"] Indications ["Suspected Beckwith-Wiedemann syndrome based on clinical features", "Family history of Beckwith-Wiedemann syndrome", "Cancer risk stratification in individuals with BWS features"] Measurement technique Confirm with laboratory Codes LOINC: 94233-2 ICD-10: Q87.3 Clinical summary This test sequences the CDKN1C gene to detect mutations associated with Beckwith-Wiedemann syndrome.
TEST-2025 CDKN2A Gene Familial Melanoma and Neural System Tumor Syndrome Genetic Test (NGS) This genetic test evaluates the CDKN2A gene for mutations associated with increased risk of familial melanoma and neural system tumors.	Whole Blood (Peripheral), Saliva, or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the CDKN2A gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Individuals with a strong family history of melanoma", "Individuals with multiple atypical nevi", "Individuals with a family history of neural system tumors"] Measurement technique Confirm with laboratory Codes LOINC: 21648-9 ICD-10: Z15.09 Clinical summary This genetic test evaluates the CDKN2A gene for mutations associated with increased risk of familial melanoma and neural system tumors.
TEST-1734 CEBPA Full Gene Mutation Analysis Test This test identifies somatic mutations in the CEBPA gene, which are critical prognostic markers in acute myeloid leukaemia (AML).	Peripheral Blood	5–6 working days from sample receipt	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations in the CEBPA gene", "Biallelic or monoallelic mutations"] Parameters [] Preparation ["No fasting or special preparation required", "Bring original doctor’s prescription", "Bring valid Emirates ID"] Indications ["Risk stratification in acute myeloid leukaemia (AML)", "Prognosis in AML", "Classification of AML subtypes", "Guiding treatment intensity"] Measurement technique Confirm with laboratory Codes LOINC: 101543-4 ICD-10: C92.00, D46.9, Z15.09 Clinical summary This test identifies somatic mutations in the CEBPA gene, which are critical prognostic markers in acute myeloid leukaemia (AML).
TEST-3675 CentoIEM Genetic Test This test evaluates over 1,200 genes for variants associated with inherited neurological and inborn-error-of-metabolism disorders using Next Generation Sequencing.	Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA	3–4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants in over 1,200 genes", "Inherited neurological disorders", "Inborn errors of metabolism"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected inherited neurological disorder", "Suspected inborn error of metabolism", "Familial risk assessment", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94474-4 ICD-10: Z13.7 Clinical summary This test evaluates over 1,200 genes for variants associated with inherited neurological and inborn-error-of-metabolism disorders using Next Generation Sequencing.
TEST-2342 CEP152 Gene Seckel Syndrome Type 5 Genetic Test This test evaluates the CEP152 gene for pathogenic variants associated with Seckel syndrome type 5.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEP152 gene sequence", "Point mutations", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Suspected Seckel syndrome type 5", "Evaluation of primordial dwarfism"] Measurement technique Confirm with laboratory Codes LOINC: 104207-2 ICD-10: Q87.1 Clinical summary This test evaluates the CEP152 gene for pathogenic variants associated with Seckel syndrome type 5.
TEST-3954 CEP290 Gene Bardet-Biedl Syndrome Type 14 Genetic Test This genetic test identifies pathogenic variants in the CEP290 gene associated with Bardet-Biedl syndrome.	Peripheral whole blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CEP290 gene exons and intron boundaries"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Confirmation of clinical diagnosis of Bardet-Biedl syndrome", "Carrier screening", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants in the CEP290 gene associated with Bardet-Biedl syndrome.
TEST-3505 CEP290 Gene Sequencing Test for Bardet-Biedl Syndrome Type 14 This test identifies pathogenic variants in the CEP290 gene, which are associated with Bardet-Biedl syndrome type 14, a rare genetic disorder.	Whole Blood, Extracted DNA, or FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEP290 gene pathogenic variants", "Coding exons", "Splice-site junctions", "Intronic coverage"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical features suggestive of Bardet-Biedl syndrome", "Family history of Bardet-Biedl syndrome", "Carrier testing for first-degree relatives"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the CEP290 gene, which are associated with Bardet-Biedl syndrome type 14, a rare genetic disorder.
TEST-6275 CETP Gene Hyperalphalipoproteinemia Genetic Test This genetic test evaluates the CETP gene for variants associated with familial hyperalphalipoproteinemia (elevated HDL-C). It identifies mutations that may alter cardiovascular ri...	Peripheral Whole Blood, Saliva, or FTA Card Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CETP gene variants", "HDL-C predisposition"] Parameters [] Preparation ["No special preparation required", "Inform phlebotomist of anticoagulant medications"] Indications ["Familial hyperalphalipoproteinemia", "Elevated HDL-C levels", "Cardiovascular risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21776-5 ICD-10: E78.8 Clinical summary This genetic test evaluates the CETP gene for variants associated with familial hyperalphalipoproteinemia (elevated HDL-C). It identifies mutations that may alter cardiovascular risk profiles.
TEST-5553 CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test This genetic test identifies pathogenic variants in the CFAP298 gene associated with primary ciliary dyskinesia type 26 (PCD26).	Whole blood (EDTA), Extracted DNA, FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFAP298 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor.", "Inform the team if you have received a whole blood transfusion or allogeneic bone marrow transplant within the last 90 days."] Indications ["Diagnosis of primary ciliary dyskinesia type 26 (PCD26)", "Individuals with clinical features suggestive of PCD26"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q34.8 Clinical summary This genetic test identifies pathogenic variants in the CFAP298 gene associated with primary ciliary dyskinesia type 26 (PCD26).
TEST-3820 CFH Gene Hemolytic Uremic Syndrome Genetic Test This test evaluates the CFH gene for mutations associated with atypical hemolytic uremic syndrome (aHUS).	Peripheral whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFH gene mutations", "Point mutations", "Small indels", "Copy number variants (CNV)"] Parameters [] Preparation ["No fasting required", "No medication cessation required unless advised by doctor", "Provide detailed family medical history", "List of current medications"] Indications ["Suspected atypical hemolytic uremic syndrome (aHUS)", "Family history of aHUS", "Need for genetic risk assessment for aHUS"] Measurement technique Confirm with laboratory Codes LOINC: 21661-6 ICD-10: D59.3 Clinical summary This test evaluates the CFH gene for mutations associated with atypical hemolytic uremic syndrome (aHUS).
TEST-4107 CFL1 Gene (Corticobasal Degeneration) Genetic Test This test evaluates the CFL1 gene for pathogenic variants associated with corticobasal degeneration.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFL1 gene", "Single nucleotide variants", "Insertions/Deletions", "Copy number alterations"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory", "Provide detailed family history", "Consent required from patient or legal guardian"] Indications ["Suspected corticobasal degeneration based on clinical presentation", "Family history of CBD or related neurodegenerative disorders", "Differential diagnosis of parkinsonism"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G31.85 Clinical summary This test evaluates the CFL1 gene for pathogenic variants associated with corticobasal degeneration.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories